Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2013 (2013), Article ID 370179, 3 pages
http://dx.doi.org/10.1155/2013/370179
Case Report

Burkitt's Lymphoma in a Pregnant Woman: Case Report and Review of the Literature

1Egas Moniz, Health Sciences Institute, Quinta da Granja, Monte de Caparica, 2829-511 Caparica, Portugal
2Serviço de Hematologia, Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Rua Professor Lima Basto, 1099-023 Lisboa, Portugal
3Serviço de Anatomia Patológica, Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Rua Professor Lima Basto, 1099-023 Lisboa, Portugal
4Instituto Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua de Jorge Viterbo Ferreira No. 228, 4050-313 Porto, Portugal

Received 30 March 2013; Accepted 20 April 2013

Academic Editors: L. Beex, J. M. Buchanich, D. V. Jones, C. V. Reyes, and K. Tanaka

Copyright © 2013 Carlos Zagalo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Booth, D. P. Burkitt, D. J. Bassett, R. A. Cooke, and J. Biddulph, “Burkitt lymphoma in Papua, New Guinea,” British Journal of Cancer, vol. 21, no. 4, pp. 657–664, 1967. View at Google Scholar · View at Scopus
  2. V. T. DeVita Jr., S. Hellman, and S. A. Rosenberg, “Non-Hodgkin lymphoma,” in Cancer: Principles and Practice of Oncology, vol. 2, pp. 2099–2139, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 8th edition, 2008. View at Google Scholar
  3. C. Bellan, L. Stefano, D. F. Giulia, E. A. Rogena, and L. Lorenzo, “Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach,” Hematological Oncology, vol. 27, no. 4, pp. 182–185, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Brady, G. J. MacArthur, and P. J. Farrell, “Epstein-Barr virus and Burkitt lymphoma,” Postgraduate Medical Journal, vol. 84, no. 993, pp. 372–377, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. J. Allday, “How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?” Seminars in Cancer Biology, vol. 19, no. 6, pp. 366–376, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Patte, A. Auperin, M. Gerrard et al., “Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients,” Blood, vol. 109, no. 7, pp. 2773–2780, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Mosse and K. Weck, Molecular Pathology of Hematolymphoid Diseases, Springer Science+Business Media, Dordrecht, The Netherlands, 2010.
  8. I. T. Aldoss, D. D. Weisenburger, K. Fu et al., “Adult Burkitt lymphoma: advances in diagnosis and treatment,” Oncology, vol. 22, no. 13, pp. 1508–1517, 2008. View at Google Scholar
  9. M. Jason and H. Azizul, “Burkitt lymphoma: pathogenesis and immune evasion,” Journal of Oncology, vol. 2010, Article ID 516047, 14 pages, 2010. View at Publisher · View at Google Scholar
  10. S. G. Holtan, D. J. Creedon, P. Haluska, and S. N. Markovic, “Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents,” Mayo Clinic Proceedings, vol. 84, no. 11, pp. 985–1000, 2009. View at Publisher · View at Google Scholar · View at Scopus